Effects of chemical conjugation of L-leucine to chitosan on dispersibility and controlled release of drug from a nanoparticulate dry powder inhaler formulation
Muhsin, Mohammad, George, Graeme, Beagley, Kenneth, Ferro, Vito, Wang, Hui, & Islam, Nazrul (2016) Effects of chemical conjugation of L-leucine to chitosan on dispersibility and controlled release of drug from a nanoparticulate dry powder inhaler formulation. Molecular Pharmaceutics, 13(5), pp. 1455-1466.
Administrators only until March 2017 | Request a copy from author
This study investigated L-leucine conjugated chitosan as a drug delivery vehicle in terms of dispersibility and controlled release from a nanoparticulate dry powder inhaler (DPI) formulation for pulmonary delivery using diltiazem hydrochloride (DH) as the model drug. DH-loaded nanoparticles of chitosan and conjugate were prepared by water-in-oil emulsification followed by glutaraldehyde crosslinking. Nanoparticles were characterised by dynamic light scattering (DLS) for particle size, X-ray Photoelectron Spectroscopy (XPS) for surface composition, and by Twin Stage Impinger (TSI) for drug dispersibility. The controlled release of DH was studied in phosphate buffered saline (PBS, pH 7.3±0.2, 37 °C) using UV spectrophotometry. The fine particle fractions (FPFs) of conjugated chitosan with and without drug were higher than those of non-conjugated chitosan nanoparticles. The conjugate nanoparticles were superior to those of unmodified chitosan in drug loading, entrapment efficiency and controlled release profile. The higher dispersibility was attributed to the amphiphilic environment of the L-leucine conjugate and hydrophobic crosslinks and the release profile reflects the greater swelling. The conjugated chitosan nanoparticles could be useful, after appropriate testing for biodegradability and toxicity, as an alternative carrier for lung drug delivery with enhanced aerosolization and prolonged drug release from nanoparticulate DPI formulations.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||nanoparticles, dry powder inhaler, pulmonary drug delivery, controlled release,, chitosan, L-leucine, diltiazem hydrochloride|
|Subjects:||Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > PHARMACOLOGY AND PHARMACEUTICAL SCIENCES (111500) > Pharmaceutical Sciences (111504)|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > Schools > School of Chemistry, Physics & Mechanical Engineering
Current > Schools > School of Clinical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
Current > QUT Faculties and Divisions > Science & Engineering Faculty
|Copyright Owner:||Copyright 2016 American Chemical Society|
|Deposited On:||29 Jun 2016 03:45|
|Last Modified:||23 Jul 2016 16:21|
Repository Staff Only: item control page